Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer
Clinical trial NCT04806464 · RECRUITING
Trial details
- NCT number
- NCT04806464
- Sponsor
- CNBG-Virogin Biotech (Shanghai) Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-16
- Primary completion
- 2022-03-21
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.